Sign in

CIK 0001501989

  • Accelerated filer

CytomX Therapeutics, Inc.

Sign in to watch
Ticker
CTMX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
273521219
Phone
+1 650-515-3185
Business address
151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Exercise or conversion Chief Medical Officer acquired 15,117 shares (option exercise)
  2. 4 Grant or award President and CEO acquired 1,979 shares (grant or award)
  3. 4 Grant or award Chief Financial Officer acquired 1,289 shares (grant or award)
  4. 4 Open-market sale Director sold 22,086 shares at $11.18 ($247,008)
  5. 4 Open-market sale Director sold 22,086 shares at $11.18 ($247,008)
  6. 4 Open-market sale Director sold 38,459 shares at an average $11.56 ($444,404)
  7. 4 Open-market sale Director sold 38,459 shares at an average $11.56 ($444,404)
  8. 4 Open-market sale Director sold 42,550 shares at $11.71 ($498,078)
  9. 4 Open-market sale Director sold 42,550 shares at $11.71 ($498,078)
  10. 4 Open-market sale Director sold 45,324 shares at an average $11.61 ($526,088)
  11. 4 Open-market sale Director sold 45,324 shares at an average $11.61 ($526,088)
  12. 4 Open-market sale Director sold 51,581 shares at an average $11.50 ($593,428)
  13. 4 Open-market sale Director sold 51,581 shares at an average $11.50 ($593,428)
  14. 4 Open-market sale Director sold 86,270 shares at an average $11.16 ($962,907)
  15. 4 Open-market sale Director sold 86,270 shares at an average $11.16 ($962,907)
  16. 4 Open-market sale Director sold 13,730 shares at $11.03 ($151,498)
  17. 4 Open-market sale Director sold 13,730 shares at $11.03 ($151,498)
  18. 4 Other disposition 10% owner disposed of 1,000,000 shares (other)
  19. 4 Other disposition Director disposed of 0 shares (other)
  20. 4 Other disposition Director disposed of 300,000 shares (other)

Page 17 of 20 · 400 filings